Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis

1 Aug 2014

Abstract excerpt

OBJECTIVES: Biological therapy represents important advances in alleviating rheumatoid arthritis (RA), but the effect on interstitial lung disease (ILD) has been controversial. The objective of this study was to assess the risk of such treatment for patients with ILD. DESIGN: Case-control cohorts. SETTING: Single centre in Japan. PARTICIPANTS: This study included 163 patients with RA who underwent biological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Share to Rheumatoid Arthritis Research and Therapies
Share to Sarcoidosis and Beryllium Toxicity Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25125479
DOI: 10.1136/bmjopen-2014-005615

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritisPMID 25125479Read ↗

Practical Approach to the Evaluation and Management of Rheumatoid Arthritis-Interstitial Lung Disease Based on its Proven and Hypothetical Mechanisms.Semantic proximity Read ↗

Recent advances in rheumatoid arthritis-associated interstitial lung disease.Semantic proximity Read ↗

The multifaceted aspects of interstitial lung disease in rheumatoid arthritis.Semantic proximity Read ↗

Safety of JAK and IL-6 inhibitors in rheumatoid arthritis: a multicentor cohort studySemantic proximity Read ↗

Change in serum KL-6 level from baseline is useful for predicting life-threatening EGFR-TKIs induced interstitial lung disease.Semantic proximity Read ↗

The phenotype of mixed connective tissue disease patients having associated interstitial lung disease.Semantic proximity Read ↗

Association of human leukocyte antigen with interstitial lung disease in rheumatoid arthritis: a protective role for shared epitope.Semantic proximity Read ↗

Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic miceSemantic proximity Read ↗

Risk-benefit analysis of isoniazid monotherapy to prevent tuberculosis in patients with rheumatic diseases exposed to prolonged, high-dose glucocorticoidsSemantic proximity Read ↗

Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.